Skip to search.
 TSX Up 0.30% TSX Ventures Down 0.15%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
0.91 Down 0.01(1.02%) Jul 2, 3:59PM EDT
Add to Portfolio
Prev Close:0.92
Open:0.90
Bid:0.80 x 10000
Ask:0.92 x 1900
1y Target Est:1.30
Beta:0.64
Earnings Date:Aug 4 - Aug 10 (Est.)
Day's Range:0.90 - 0.95
52wk Range:0.80 - 2.78
Volume:35,784
Avg Vol (3m):488,254
Market Cap:11.08M
P/E (ttm):N/A
EPS (ttm):-1.59
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
DCTHDown 1.02%11.08M
LLYUp 1.52%91.22B
PFEDown 0.95%205.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:4.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback